We focus on the development and commercialization of transformative products that address what we believe are the most critical, unmet healthcare needs. Our unique structure allows us to develop complete financing solutions in both private and public markets, and every one of our investments gets attention from each member of our investment team. We call it radical collaboration.
We invest in emerging leaders across all areas of healthcare including therapeutics, devices, diagnostics, and services. Data science drives our decision-making framework, and we have a special interest in companies that are ushering in healthcare transformation through data science and machine learning applied to human biology data.
What Makes Us Unique
Full Lifecycle Investing. We are a financial partner at all stages – venture and post-venture, private, and public – partnering at the point where we believe we can make the biggest impact.
Radical Collaboration. Our firm is structured to be free of arbitrary silos or competition. Our team of investment analysts, MD/PhDs and data scientists work with each and every company we invest in.
Industry Know-How. We bring a depth and breadth of insights and best practices from our experience with hundreds of companies.
Networked. We have powerful, high-quality networks across areas of healthcare including marketing, sales, business development, research and development, regulatory, policy, and communications.
The healthcare sector is experiencing unprecedented innovation driven by understanding vast amounts of biologic and genetic information; a change we believe is leading to some of the most impactful medical solutions in decades. Our passion is to use our capital and networks to help build transformative healthcare companies ahead of this revolution, and significantly impact the quality and effectiveness of the U.S. healthcare system.